An Open Label Prostate Cancer Study in Japanese Patients

Summary

The primary aim of study is to gain an initial assessment of safety and tolerability of AZD3514 in Japanese patients together with assessing Pharmacokinetics (PK) and gaining a preliminary assessment of anti-tumour action. In this study, AZD3514 will be administered to Japanese patients with metastatic castration resistant prostate cancer.

Timeline

Start

2011-08

Primary completion

2013-03

Completion

2013-05

Drugs

Indications